Chenomx and Umetrics announce a partnership to provide a comprehensive metabolomics solution to researchers worldwide
This partnership combines Chenomx's powerful and easy-to-use metabolic profiling software with Umetrics's proven multivariate analysis software, providing researchers with a turn-key solution for discovering biologically relevant patterns in NMR spectra.
"Metabolomics researchers are faced with two key challenges," explains Jack Newton, director of product development for Chenomx.
"First, they must analyse large NMR data sets, potentially consisting of thousands of NMR spectra, to find meaningful patterns in their data".
"Translating these patterns into biologically relevant information in the form of metabolite identification and quantification is the second key challenge".
"These two processes are tightly coupled, and the decision to partner with Umetrics to make the process as intuitive and as effortless as possible for the end-user was a natural one." Jan Wahlstrom, European CEO and sales manager, adds: "This partnership is great news for scientists working in metabonomics and metabolomics as it provides them with a seamless interface between data collection and data analysis, allowing them to get on with the science".
Chenomx is a privately-held Canadian company that specialises in the development of complex mixture analysis software for broad application in life science technologies.
With world-class expertise in NMR spectroscopy, pharmaceutical sciences, and computer software, Chenomx offers a broad range of software products and compound databases to support the metabolomics communities' research efforts.
Chenomx's flagship product, Chenomx NMR Suite, provides a rich set of tools for identifying and quantifying metabolites in complex NMR Spectra.
Umetrics is a leading-edge software company which supplies data analysis software and training courses in multivariate analysis and design of experiments.
Umetrics provide solutions for both off-line and on-line applications to a broad range of companies, particularly from the pharmaceutical, biotech and chemical sectors.
Umetrics was recently acquired by MKS Instruments, a worldwide provider of monitoring and control technologies.
